Related Experiment Video
Updated: Mar 2, 2026

A New Method for Inducing a Depression-Like Behavior in Rats
Published on: February 22, 2018
[Anxiety and depressive disorders in Parkinson's disease]
G N Akhmadeeva1, R V Magzhanov2, G N Tayupova3
1Kuvatova Rebublic Clinical Hospital, Ufa, Russia; Rebublic Consultative Diagnostic Centre of the Extrapyramidal Pathology and the botulinotherapy, Ufa, Russia; Institute of Biochemistry and Genetics of Ufa Science Centre, Ufa, Russia.
Abstract:
This review presents the most recent data of worldwide research on anxiety and depressive disorders in patients with Parkinson's disease. Their characteristics and epidemiology, pathogenetic and clinical features, methods of diagnosis and treatment are presented. Depression occurs in 40-50% of patients with PD, anxiety in 17-43% of patients. Pramipexole, a dopamine agonist, is only one drug recommended for depression treatment. Nortriptyline and desipramine, belonging to the group of tricyclic antidepressants (TCAs), are considered to be possibly effective. There are no clear recommendations for treatment of anxiety. In general, methods of therapy of anxiety and depressive disorders in PD are not well understood which determines the conduct of large-scale studies in the future.
Related Concept Videos
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Depressive Disorders: MDD and Dysthymia
Personality Disorders: Paranoid and Schizoid
Paranoid Personality Disorder
Paranoid personality disorder is...
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Panic Disorder
